sulfasalazine has been researched along with Diabetes Mellitus, Type 2 in 4 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mikkelsen, RR | 1 |
| Hundahl, MP | 1 |
| Torp, CK | 1 |
| RodrÃguez-Carrio, J | 1 |
| Kjolby, M | 1 |
| Bruun, JM | 1 |
| Kragstrup, TW | 1 |
| Lappas, M | 1 |
| Yee, K | 1 |
| Permezel, M | 1 |
| Rice, GE | 1 |
| Haas, RM | 1 |
| Li, P | 1 |
| Chu, JW | 1 |
| Tack, CJ | 1 |
| Lutterman, JA | 1 |
1 review available for sulfasalazine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Immunomodulatory and immunosuppressive therapies in cardiovascular disease and type 2 diabetes mellitus: A bedside-to-bench approach.
Topics: Animals; Antibodies, Monoclonal, Humanized; Cardiovascular Diseases; Colchicine; Diabetes Mellitus, | 2022 |
3 other studies available for sulfasalazine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Sulfasalazine and BAY 11-7082 interfere with the nuclear factor-kappa B and I kappa B kinase pathway to regulate the release of proinflammatory cytokines from human adipose tissue and skeletal muscle in vitro.
Topics: Adiponectin; Adipose Tissue; Adult; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Cell | 2005 |
Glucose-lowering effects of sulfasalazine in type 2 diabetes.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Diabetes Mellitus, Type 2; Female; Hu | 2005 |
[Problems in the interpretation of the percentage of glycosylated hemoglobin in patients with diabetes mellitus].
Topics: Adult; Aged; Anemia, Hemolytic, Autoimmune; Anemia, Iron-Deficiency; Chromatography, High Pressure L | 1995 |